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Abstract
Human apurinic/apyrimidinic endonuclease 1 (APE1) is a key enzyme in the base excision repair (BER) and nucleotide
incision repair (NIR) pathways. We recently analyzed the conformational dynamics and kinetic mechanism of wild-type (wt)
protein, in a stopped-flow fluorescence study. In this study, we investigated the mutant enzyme APE1K98A using the same
approach. Lys98 was known to hydrogen bond to the carboxyl group of Asp70, a residue implicated in binding the divalent
metal ion. Our data suggested that the conformational selection and induced fit occur during the enzyme action. We
expanded upon the evidence that APE1 can pre-exist in two conformations. The isomerization of an enzyme-product
complex in the BER process and the additional isomerization stage of enzyme-substrate complex in the NIR process were
established for APE1K98A. These stages had not been registered for the wtAPE1. We found that the K98A substitution
resulted in a 12-fold reduction of catalytic constant of 59-phosphodiester bond hydrolysis in (3-hydroxytetrahydrofuran-2-
yl)methyl phosphate (F, tetrahydrofuran) containing substrate, and in 200-fold reduction in 5,6-dihydrouridine (DHU)
containing substrate. Thus, the K98A substitution influenced NIR more than BER. We demonstrated that the K98A mutation
influenced the formation of primary unspecific enzyme-substrate complex in a complicated manner, depending on the
Mg
2+ concentration and pH. This mutation obstructed the induced fit of enzyme in the complex with undamaged DNA and
F-containing DNA and appreciably decreased the stability of primary complex upon interaction of enzyme with DNA,
containing the natural apurinic/apyrimidinic (AP) site. Furthermore, it significantly delayed the activation of the less active
form of enzyme during NIR and slowed down the conformational conversion of the complex of enzyme with the cleavage
product of DHU-substrate. Our data revealed that APE1 uses the same active site to catalyze the cleavage of DHU- and AP-
substrates.
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Introduction
There are a number of DNA lesions that continuously arise in
the human genome, resulting in cell death, tumors, autoimmune
diseases and aging. It was estimated that about 10
4 of DNA lesions
were generated per mammalian cell per day [1]. The majority of
DNA damage can arise either spontaneously or following exposure
to reactive oxygen species, derived from a wide range of cellular
processes. At present, nearly one hundred different types of
damages of heterocyclic bases and sugar-phosphodiester backbone
have been identified [2].
Cellular genome integrity is sustained by several distinct repair
mechanisms that remove DNA damage. The majority of the
damaged DNA bases are eliminated through the base excision
repair (BER) pathway [2]. BER is initiated by DNA glycosylases,
enzymes that excise damaged and/or mispaired bases to produce
apurinic/apyrimidinic sites (AP sites). AP sites also occur through
the spontaneous loss of bases (mainly purines) [2–4]. AP sites can
block DNA replication and transcription and, if bypassed, direct
preferential incorporation of A by DNA polymerases [5] that
results in single-nucleotide substitution in DNA. During BER
DNA is hydrolytically nicked 59 to the AP site by apurinic/
apyrimidinic endonucleases (AP endonucleases). APE1 (35.5 kDa)
is the major AP endonuclease in human cells [6,7].
Repair of certain oxidative base lesions can be initiated directly
by the AP endonucleases alone, during nucleotide incision repair
(NIR) [8–13], by-passing the DNA glycosylase step. During this
process, an AP endonuclease introduces a nick 59 to the damaged
deoxynucleotide, generating a 39-hydroxyl terminus and a 59-
phosphate terminus. The 39-hydroxyl terminus provides a proper
primer for DNA repair synthesis. The dangling damaged
nucleotide then can be removed by a flap endonuclease 1 [14].
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AP-intermediates [8]. In human cells, NIR is performed by the AP
endonuclease APE1 [10]. APE1 was shown to cleave DNA
containing 5,6-dihydropyrimidines, a-29-deoxyadenosine, a-thy-
midine, a-29-deoxycytidine, 5-hydroxy-29-deoxyuridine, and 5-
hydroxy-29-deoxycytidine [10,12,13].
It was revealed [15] that the 39-phosphodiesterase and AP
endonuclease activities of the inactive APE1E96A mutant
(glutamate-96 was replaced by alanine) were essentially restored
to the wild-type protein level in the presence of the second site
mutation, K98R (lysine-98 was replaced by arginine). Based on the
CD spectra analysis, it was shown that single mutations E96A and
K98R or the double mutation E96AK98R did not significantly
perturb the protein conformation. However, the APE1K98R and
APE1E96AK98R mutants exhibit identical fluorescence emission
spectra with lower intensity in comparison to those of the wild-type
protein and APE1E96A mutant. The latter two proteins exhibit
identical emission spectra. Thus, the K98R mutation has an
influence on the structural environment surrounding the trypto-
phan residues of APE1. Glutamate-96 plays an important role in
the co-ordination of the cofactor Mg
2+. Substitution of glutamate-
96 with alanine results in an approximately 400-fold loss of the
endonuclease activity [16–18]. Restoration of enzymatic activity in
the double mutant APE1E96AK98R indicates that the substitu-
tion of lysine-98 leads to the formation of an alternative structure.
This structure provides efficient Mg
2+ coordination without
involvement of glutamate-96 [15]. Lys98 was shown to take part
in the coordination of Mg
2+, as it hydrogen bonds to the carboxyl
group of Asp70 [18]. The latter residue is implicated together with
Glu96 in binding the divalent metal ion in the metal binding site,
the so-called site A. Besides, the second metal binding site (site B)
was found in APE1 at a neutral pH. This site is composed of the
side-chains of Asp210, Asn212 and His309. The metal ion in the
site A contributes to the stabilization of the transition state
intermediate and the 39-leaving group. The metal in the site B is
likely to stabilize the hydroxyl ion that is supposed to act as the
nucleophile. This metal is also in a favorable position to neutralize
the negative charge of the phosphorane transition-state interme-
diate [18–20]. In addition, there is an assumption that one Mg
2+
ion moves from the B- to the A-site during substrate cleavage [21].
Many DNA repair enzymes are active versus several structurally
different substrates [22–23]. Different enzyme conformations are
able to recognize these substrates. APE1 also cleaves structurally
different substrates. Therefore, the investigation of the influence of
different APE1 conformations on the BER and NIR activities is of
significant interest.
Recently we proposed [24] that at the initial moment, some
enzyme molecules existed in the conformation E1, which was
highly active towards DHU-substrate cleavage, whereas a fraction
of the enzyme molecules existed in the less active conformation,
E2. The less active E2 form of the enzyme can either participate
directly in the formation of the initial enzyme–substrate complex,
or can be in slow equilibrium with the more active E1 form. Both
the complex formation of E2 with the substrate and the
conformational transition of E2 into E1 are strongly shifted
backward. Furthermore, we demonstrated [24] that APE1
hydrolytically cleaved the DHU-substrate during the NIR
pathway and the AP-substrate during the BER pathway with
comparable rates.
In the present study, we expand upon the evidence that APE1
can exist in two alternative and distinct conformations. As the
mutation of lysine-98 influenced the conformation of APE1, we
performed a detailed investigation into how the substitution of
lysine-98 with alanine (K98A) affected the enzyme activity in the
NIR and BER pathways. To achieve this, we determined the
kinetic parameters of the individual stages of APE1K98A action,
using the stopped-flow approach. The comparison of the kinetic
constants of the mutant to those of wtAPE1 provides us with a
view of the mechanistic role of lysine-98. We demonstrate that
during both BER and NIR, Lys-98 contributes significantly in the
59-phosphodiester bond hydrolysis of DNA substrate, but not in
the dissociation of the enzyme-product complex. This amino acid
substitution influences the catalysis in NIR more than in BER. We
also demonstrate the influence of K98A substitution upon the
other stages of BER and NIR processes. Based on these data, we
suggest that APE1 uses the same active site to catalyze the cleavage
of DHU- and AP-substrates. The protein is probably able to form
different conformations in the region of the active site, which are
responsible for the incision of such structurally unrelated lesions as
AP site and DHU.
Materials and Methods
Enzyme and oligonucleotides
The mutant APE1K98A protein was expressed in AP
endonuclease-deficient Escherichia coli xth nfo cells (BH110).
Escherichia coli strain BH110 (DE3 nfo::kan
R [D(xth-pncA)90
X::Tn10]) derivative of AB1157 (IeuB6 thr-1 D(gpt-proA2) hisG4
argE3 lacY1 gaIK2 ara-14 mtl-1 xyl-5 thi-1 tsx-33 rpsL31 supE44 r)
(WT) was from the laboratory stock [12]. APE1K98A was
constructed and purified as described in [25].
Oligodeoxyribonucleotides (ODNs) (ATGCACATCGTCTA-
CATGCGTATGCAGTCA), d(TGACTGCATAXGCATGTA-
GACGATGTGCAT) (X=C, F, U or DHU), d(TGACTGCA-
T(2-aPu)XGCATGTAGACGATGTGCAT) (X=DHU or C, 2-
aPu – 2-aminopurine is a highly fluorescent analogue of adenine),
d(TGACTGCATA(DHU)(2-aPu)CATGTAGACGATGTGCA-
T), d(TGACTGCATA) and pd(XGCATGTAGACGATGTG-
CAT) (X=F or DHU) were synthesized in the Laboratory of
Bionanotechnology (Institute of Chemical Biology and Funda-
mental Medicine, Siberian Branch of the Russian Academy of
Sciences) by the standard phosphoramidite method and purified by
an anion exchange and reversed phase HPLC. The concentration
of each individual ssODN was ascertained via the absorbance at
260 nm with the extinction coefficients calculated from the nearest-
neighbor data for mono- and dinucleotides [26]. In order to
generate the AP site d(TGACTGCATAUGCATGTAGAC-
GATGTGCAT) was treated with uracil-DNA glycosylase [27].
When necessary, 59-termini of the ODNs d(TGACTGCATAXG-
CATGTAGACGATGTGCAT) (X=F, AP or DHU) were labeled
with
32P according to the standard procedure [28] using T4 polynu-
cleotide kinase (10–20 U; SibEnzyme, Russia) and [c-
32P]ATP
(Biosan, Russia). The oligonucleotide duplexes used in this study are
presented in Figure 1.
Stopped-flow kinetics
The kinetics of APE1K98A interactions with DNA substrates
was investigated using the stopped-flow method. The kinetic
curves were recorded at 25uC with an SX.18MV stopped-flow
spectrometer (Applied Photophysics Ltd, Great Britain) detecting
the signal of either protein tryptophan residues or substrate 2-aPu
residues. Fluorescence excitation and emission maxima of Trp
residues in APE1 were observed at lex=281 nm and lem=
330 nm, respectively [29]. The Trp fluorescence emission of
APE1K98A was detected through a long-pass Schott filter WG320
at lem.320 nm with excitation at 281 nm. The 2-aPu fluores-
cence emission was detected through a long-pass Corion filter LG-
370 at lem.370 nm with excitation at 310 nm. The fluorescence
Kinetics of APE1K98A in BER and NIR Pathways
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The dead time of the instrument was 1.37 ms. The signal points
were collected at $2 ms, except for the case of APE1K98A
interaction with the C/G ligand in the BER buffer, where the data
at $1.5 ms were used. The reaction was carried out in BER
(20 mM HEPES/KOH pH 7.5, 50 mM KCl, 5 mM MgCl2) and
NIR (20 mM HEPES/KOH pH 6.8, 50 mM KCl, 0.01 mM
MgCl2) buffers. The Trp fluorescence of APE1K98A was recorded
for 1 mM concentration of protein in the reaction chamber, and
the 0.75–3.0 mM concentration of dsODN substrate. The 2-aPu
fluorescence was measured for 1 mM substrate concentration in
the reaction chamber, and 0.75–1.5 mM of APE1K98A concen-
tration. During short time periods, each kinetic curve was the
average of four or more experiments. For longer times, no
averaging was performed. The data were processed using the non-
linear regression analysis with the DynaFit software (BioKin, USA)
[30]. The kinetic curves were analyzed as previously described
[29].
Steady-state Fluorescence Titration
In order to analyze the affinity of APE1K98A for the reaction
product, the enzyme was titrated under steady-state conditions
with the ODNs reconstituting the products of DNA cleavage. The
Trp fluorescence emission of protein was measured at 330 nm
(lex=281 nm) using the Cary Eclipse spectrofluorometer. The
excitation and emission wavelengths were adjusted using the
monochromators equipping the instrument. Each point of the
fluorescence titration curve was obtained by measurement of the
fluorescence intensity of separate solutions (80 ml) containing the
enzyme (1 mM) and ODN ligand (0.1–7 mM). Each mixture was
incubated at 25uC for 10 min before being measured in either the
BER or NIR buffer. Fluorescence intensity values (F) in the
presence of oligonucleotides were corrected for the inner filter
effect due to oligonucleotides absorption at 281 nm using the
equation:
Fc~F|100:5Aex
where Fc is the fluorescence intensity at the particular wavelength,
corrected for the inner filter effect, and Aex is the absorbance of the
oligonucleotides at 281 nm. The dissociation constant (Kd) was
calculated based on the dependence of the enzyme fluorescence
intensity on the ligand concentration, as described in [29].
Substrate Cleavage
The time courses of cleavage for 59-[
32P]-labeled specific
substrates were obtained in the presence of 1 mM APE1K98A
and at substrate concentrations of 1, 1.25, and 1.5 mM. The
reaction was carried out at 25uC in the BER buffer for F- and AP-
containing substrates, and in the NIR buffer for the DHU-
containing substrate. The enzyme was rapidly added to the
corresponding
32P-labeled substrate. The reaction was quenched
at designated intervals by the addition of reaction mixture aliquots
into a solution containing 7 M urea with marker dyes. The nicked
products were separated in 20% denaturing PAGE. The gels were
dried, visualized using a Molecular Imager FX phosphorimager
(Bio-Rad, USA), and quantified using the Gel-Pro Analyzer
software (Media Cybernetics, USA). The data obtained for DHU-
substrate were analyzed with the DynaFit software (BioKin, USA)
[30].
Results
Interaction of APE1K98A with undamaged ligand in BER
and NIR buffers
The interaction of APE1K98A with the undamaged 30-mer
DNA ligand (C/G) resulted only in the formation of the enzyme-
Figure 1. Schematic presentation of various DNA duplexes used in this study.
doi:10.1371/journal.pone.0024063.g001
Kinetics of APE1K98A in BER and NIR Pathways
PLoS ONE | www.plosone.org 3 September 2011 | Volume 6 | Issue 9 | e24063substrate complex. Initially, a decrease in the protein fluorescence
intensity occurred in the BER buffer during the time range of 0–
10 ms (Figure 2A), and in the NIR buffer during the time range of
0–40 ms (Figure 2B). The fluorescence intensity then showed an
increase, and the traces entered a plateau phase at times exceeding
10–20 ms in the BER buffer, and 50 ms in the NIR buffer. The
decrease likely reflected the formation of an initial non-specific
complex. It was supposed that the following increase in the
fluorescence corresponded to the isomerization of the initial
complex to yield the second protein-DNA complex. During this
process the protein underwent conformational adjustment. Such
double-stage binding in both BER and NIR buffers was described
by the kinetic scheme presented in Figure 3. Processing of the
kinetic curves according to this scheme provided the rate constants
values of APE1K98A interaction with the C/G ligand (Table 1).
Interaction of APE1K98A with F- and AP-substrates in BER
buffer
Except for the natural AP site, human AP-endonuclease can
recognize and process the synthetic analog of deoxyribose, (3-
hydroxytetrahydrofuran-2-yl) methyl phosphate (F). Herein, we
investigated the conformational dynamics of APE1K98A interac-
tion with the substrates containing both the natural AP site and the
F-residue in the BER buffer.
Experiments with [
32P]-labeled substrates AP/G and F/G
analyzing the product accumulation revealed that at the used
concentrations, the enzyme cleaved these substrates completely at
the first time point sampled (,10 s, data not shown).
Upon interaction of the enzyme with both specific substrates the
changes in fluorescence intensities on the kinetic curves were
stronger than in the case of the C/G ligand (Figure 4).
In the case of the substrate F/G the fluorescence intensity was
decreasing for ,10–20 ms. The fluorescence curves then
underwent a kink at around 0.1 s, which was followed by a slow
decrease in fluorescence. The fluorescence traces were fit to kinetic
schemes containing a single or a double binding equilibrium
(Figure 4A). The double-equilibrium binding scheme matches the
data better. Values of standard deviations for the double-
equilibrium binding scheme were lower than that for the single-
equilibrium binding scheme. These results suggested that the
formation of the initial enzyme-substrate complex was followed by
the isomerization of this complex.
Based on the data obtained we have proposed the kinetic
scheme describing the mechanism of the F-substrate conversion by
APE1K98A in the BER pathway (Figure 5). This scheme includes
two reversible steps: initial complex formation and isomerization,
followed by an irreversible step of 59-phosphodiester bond
hydrolysis, a reversible step of enzyme-product complex isomer-
ization, and a reversible step of enzyme dissociation from the
complex with the product. Figure 4A clearly illustrates that
fluorescence intensities do not return to their initial values. This
indicates that the terminal dissociation step is not reflected on the
fluorescence kinetic curves. Thus, the enzyme-product complex is
rather stable. The rate constants values of APE1K98A interaction
with specific substrate F/G are presented in Table 2.
The APE1K98A reaction with the substrate AP/G was
accompanied by a decrease in the fluorescence intensity for
,10–30 ms (Figure 4B). The subsequent changes in fluorescence
intensity were less pronounced than that for the substrate F/G.
The kinetic traces of enzyme interaction with AP/G allowed us to
fit only the rate constants of the first two reversible steps
corresponding to the initial complex formation and its isomeriza-
tion (Table 2). Thus only the initial decrease in the fluorescence
intensity up to 15 ms was quantitatively processed. At the same
time the shapes of kinetic curves for both specific substrates were
similar. According to these data we assumed that the number of
kinetic stages during the enzyme interaction with the substrates
AP/G and F/G was equal (Figure 5).
The fluorescence titration of protein with reaction product was
performed under steady-state conditions, in order to determine the
equilibrium dissociation constant for the complex of APE1K98A with
the product (KP). The reaction product containing an AP site at the
59-terminus at the site of the nick was very unstable [31]. Therefore,
three oligonucleotides were used to reconstitute a reaction product
with an F-residue at the 59-terminus at the site of the nick. Such a
complex was stable at the reaction temperature (25uC) [29] (see
Materials and Methods). APE1K98A was titrated with this complex
and changes in the Trp fluorescence intensity were recorded (data not
shown). The resulting KP value was 0.4460.1 mM.
Interaction of APE1K98A with DHU-substrate in NIR
buffer
5,6-Dihydropyrimidines are major DNA base lesions generated
by c-irradiation under anoxic conditions [32]. They are substrates
Figure 2. Trp fluorescence traces of APE1K98A (1 mM) upon binding with the C/G ligand. The kinetic curves were recorded in the BER (A)
and NIR (B) buffers. Smooth curves are a result of the fitting procedure. Concentrations of C/G are indicated next to the right axis.
doi:10.1371/journal.pone.0024063.g002
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investigated the APE1K98A interaction with the DHU-containing
substrate.
APE1K98A cleavage of [
32P]-labeled DHU-substrate
We obtained the time course of accumulation of incised
product, during processing of 59-[
32P]-labeled DHU-substrate by
APE1K98A in NIR buffer (Figure 6). Mutant protein was found to
cleave about 35% of substrate during 35 hours (Figure 6), whereas
APE1 cleaved slightly more than 60% of substrate during the same
amount of time [24]. Apparently, mutant protein form operated
more slowly than the wild-type protein.
Three phases could be recognized on the kinetic curves of
product accumulation (Figure 6). Within the first phase in the time
range ,100 s the rapid product accumulation with reaching an
intermediate plateau was observed. During the next two phases
the products accumulated more slowly. The concentration of
products generated during the first phase of the process was lower
than the initial concentration of the enzyme (Figure 6). It
amounted to ,15% of the initial substrate concentration. The
same result was observed in the case of the wild-type protein [24].
In all likelihood, the mutant form APE1K98A behaves like the
wild-type protein when binding the DHU-substrate. The de-
creased amplitude of initial product accumulation suggests that the
enzyme exists in the equilibrium at least between two conforma-
tions.
The second phase of product accumulation was observed at
100,t,20000 s. The third phase corresponded to an extremely
slow accumulation of the product and continued at t.20000 s.
The slow biphasic accumulation of the product makes a strong
case for a reaction with a less active form of the enzyme and for an
existence of the stable enzyme-product complex (Figure 6).
Kinetic traces of 2-aPu fluorescence of DHU-substrates
upon the interaction with APE1K98A
We examined the changes in fluorescence intensity of a 2-aPu
residue located in the substrate at the 59-side of DHU in the
presence of enzyme in NIR buffer, in order to determine the
kinetic mechanism of APE1K98A interaction with DHU-sub-
strate. Although no changes were observed in the 2-aPu
fluorescence intensity upon APE1K98A binding with undamaged
DNA ((2-aPu)C/G) (data not shown), the changes of 2-aPu
fluorescence intensity were observed with (2-aPu)DHU/G sub-
strate. The shapes of kinetic curves were the same as in the case of
the wild-type protein [24], however the processes occurred more
slowly (Figure 7). It was possible to differentiate between three
phases on these curves. Within the initial rapid phase (,20 s
(Figure 7)) the 2-aPu fluorescence intensity increased, reaching an
intermediate plateau. This initial burst of the fluorescence intensity
coincided with the phase of the initial accumulation of product of
[
32P]-DHU/G substrate cleavage (Figure 6, Phase 1). The second
phase of the fluorescence intensity increase was observed up to
,4000 s. The beginning of the third phase was recorded at
.4000 s. (Figure 7). The latter phase corresponded to the third
phase of the slow accumulation of product of [
32P]-DHU/G
substrate cleavage (Figure 6).
In addition, we examined the APE1K98A interaction with the
substrate DHU(2-aPu)/G, which contained 2-aPu residue located
at the 39-side of DHU, in NIR buffer. No significant changes of 2-
aPu fluorescence intensity were registered up to 7000 s (data not
shown).
Kinetic changes of Trp fluorescence intensity upon the
interaction of APE1K98A with DHU-substrate
The conformational changes of APE1K98A upon its interaction
with the substrate DHU/G were measured by the tryptophan
fluorescence of protein in NIR buffer. As shown in Figure 8 the
fluorescence intensity sharply decreased up to 0.1 s with substrate
concentrations 0.75 mM, 1 mM, and up to 1 s with substrate
concentrations 1.25 mM, 1.5 mM, 2 mM. Then the fluorescence
signal decreased more slowly. Thus for substrate concentrations
$1.25 mM it was possible to observe the additional stage, absent in
the case of lower substrate concentrations. If the time exceeded
10 s, the protein bleaching became noticeable. This fact was
observed during the registration of protein fluorescence traces in
the absence of substrate (data not shown). The shapes of kinetic
curves after the correction of bleaching became ambiguous.
Therefore, we registered the Trp fluorescence only up to 10 s.
The decrease of protein fluorescence intensity in the time range
$1 s (Figure 8) was consistent with the initial increase in (2-
aPu)DHU/G fluorescence intensity (Figure 7, Phase 1). Hence,
this decrease corresponded to the first rapid phase of substrate
cleavage. We suggest that the mutant protein exists in two
conformations, as in the case of wtAPE1 [24]. At the initial
moment one part of the enzyme exists in the conformation E1,
which is energetically less advantageous but more active for DHU-
substrate cleavage. Another part of the enzyme exists in the
conformation E2, which is energetically more advantageous but
significantly less active for the cleavage of this substrate. Therefore
the initial sharp decrease of protein fluorescence intensity (Figure 8)
is likely to correspond to the substrate binding by the E1 form of
enzyme, and to the subsequent isomerization of this complex.
Kinetic scheme of APE1K98A action in the nucleotide
incision repair pathway
Analysis of Trp fluorescence traces of APE1K98A interacting
with DHU/G (Figure 8) reveals the existence of four stages
corresponding to the initial complex formation of E1 with the
substrate, two stages of complex isomerization, and the stage of
chemical cleavage of substrate (Figure 9). The forward and reverse
rate constants of formation of initial enzyme-substrate complex
(kbind
on , kbind
off ), and of this complex isomerization (kES1 isom
on ,
Figure 3. The kinetic scheme describing the interactions of
APE1K98A with undamaged ligand.
doi:10.1371/journal.pone.0024063.g003
Table 1. Rate constants of APE1K98A and APE1 binding with
undamaged C/G ligand.
APE1K98A APE1
(a)
Constants BER buffer NIR buffer BER buffer NIR buffer
kbind
on (M
21 s
21) (2.060.1)610
6 (3.860.1)610
6 1.1610
7 4.4610
5
kbind
off (s
21) 78627 1 612 0 0 1 2
kES1 isom
on (s
21) 8.360.1 0.2360.01 16 0.82
kES1 isom
off (s
21) 59612 8 60.5 80 1.5
aData taken from [29].
doi:10.1371/journal.pone.0024063.t001
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off , kES2 isom
on , kES2 isom
off ), as well as the rate constant of
substrate cleavage (k
cut) (Figure 9) are presented in Table 3. Only
the initial steps corresponding to the first two equilibrium stages
can be quantitatively processed on kinetic curves, obtained for low
DHU/G concentrations 0.75 mM and 1 mM.
The reaction progress curves for cleavage of [
32P]-DHU-
substrate by APE1K98A (Figure 6) illustrate the three phase
behavior. Based on the proposed kinetic scheme (Figure 9) it can
be supposed that the first burst phase corresponds to the activity of
enzyme existing in the more active conformation E1 (Figure 6,
Phase 1). The slower second stage, as in the case of the wild-type
protein, is limited either by the rate of the direct enzyme-substrate
complex formation of the less active enzyme form E2 or by the
rate of conformational transition of E2 into E1 (Figure 6, Phase 2).
The third, slowest stage can be attributed to the process of
APE1K98A release from the complex with the nicked product
(Figure 6, Phase 3). The latter stage seems to be limiting the overall
enzymatic process and determining its rate in the steady-state
conditions. The rate constants of the first (k
cut), second (kbind
inact), and
third (k
EP diss) phases are presented in Table 3.
2-aPu fluorescence traces recorded for (2-aPu)DHU/G sub-
strate upon interaction with APE1K98A (Figure 7) also demon-
strate the three phase character. Apparently, the first phase
corresponds to the rapid chemical substrate cleavage by the
enzyme. As in the case of wild-type protein, we suggest that the
second phase in Figure 7 is limited by a slow conformational
change of the APE1K98A complex with the nicked product.
Hence, this second phase does not correspond to the process
limiting the second stage of accumulation of the [
32P]-labeled
substrate nicked product (Figure 6). The rate constants corre-
sponding to the first (k
cut) and second (k
EP isom) phases
differentiated in Figure 7 are presented in Table 3. One can see
that the second phase of slow 2-aPu fluorescence intensity increase
(Figure 7) is limited by the more rapid process (k
EP isom) than the
second phase in Figure 6 (kbind
inact). The third phase (Figure 7) was
ascribed to the enzyme release from the stable complex with the
product. Due to the fact that only the beginning of process was
observed on kinetic curves, there was no opportunity to
quantitatively process the latter phase.
The values of rate constants of chemical cleavage (k
cut) obtained
from the kinetic curves of APE1K98A interaction with substrates
DHU/G (Trp fluorescence detection), (2-aPu)DHU/G (2-aPu
fluorescence detection), and [
32P]-DHU/G (detection of product
accumulation) showed a high degree of similarity (Table 3). The rate
constant of limiting stage corresponding to release of APE1K98A from
the complex with the product (k
EP diss=1.2 610
25 s
21,T a b l e3 )
coincides with the appropriate value forAPE1 (k
EP diss=1.3 610
25 s
21)
[24].
The equilibrium constant for dissociation of APE1K98A
complex with the product KP was determined by the fluorescence
titration with the reaction product under steady-state conditions,
as described earlier (data not shown). To reconstitute the reaction
product we used the nicked oligonucleotide duplex containing the
DHU residue at the 59-terminus at the site of the nick. The fitting
value of KP is equal to 1.960.2 mM.
Discussion
To incise the DNA sugar-phosphate backbone at 59 to such
structurally unrelated lesions as AP site and DHU, it is necessary
that APE1 should undergo the conformational change of its active
site region. In accordance with the concept of conformational
selection [33,34], all proteins pre-exist in a dynamic equilibrium
between various conformations. Multiple-ligand binding at a single
site simply reflects the existence of the distribution of conforma-
tional isomers of enzyme in solution. The ligand defines the
Figure 4. Trp fluorescence traces of APE1K98A (1 mM) interacting with substrates F/G (A) and AP/G (B). The reactions were carried out in
BER buffer. Smooth curves are the result of the fitting procedure. Traces were fitted to kinetic schemes containing a single (A, dashed curves) or a
double (A, B, solid curves) binding equilibrium. Concentrations of the substrates are indicated next to the right axis.
doi:10.1371/journal.pone.0024063.g004
Figure 5. The kinetic scheme describing the interactions of APE1K98A with specific F- and AP-substrates during BER.
doi:10.1371/journal.pone.0024063.g005
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different conformers. The range of dissimilar ligands that will bind
is dependent upon the distribution and redistribution of the
conformations. Mutations in protein are likely to lead to
population shifts in pre-existing conformers. It is known, that
Lys98 takes part in coordination of Mg
2+, as it hydrogen bonds to
the carboxyl group of Asp70, a residue implicated in binding the
divalent metal ion in the metal binding site A [18]. The metal ion
in this site was shown to play a role in stabilizing the transition
state intermediate and the 39-leaving group [18–20]. Furthermore,
the substitution of lysine-98 leads to the formation of an alternative
structure [15] near the active site. It should influence the kinetic
behavior of the enzyme. In the present study, the pre-steady-state
kinetic analysis of APE1K98A mutant reveals a detailed view of
the role of lysine-98 in the enzymatic catalysis. Our data implies
that the conformational selection does take place upon the protein
binding of DHU-substrate and that the enzyme pre-exists in the
equilibrium at least between two conformations. What is more, the
enzyme in the complex with ligands undergoes the conformational
changes, indicating that the induced fit pathway takes place in
addition to conformational selection.
APE1K98A interaction with undamaged ligand
The interactions of APE1K98A with undamaged ligand C/G in
both BER and NIR buffers are described by the kinetic scheme
presented in Figure 3. This scheme includes two reversible
equilibrium stages: formation of the initial enzyme-substrate
complex and the isomerization of this complex. In different
buffers the corresponding rate constants of the individual reaction
steps are varied, illuminating the effect of pH and Mg
2+ on the
Table 2. Rate constants of APE1K98A and APE1 interactions
with specific F- and AP-substrates in BER buffer.
APE1K98A APE1
(a)
Constants F/G AP/G F/G AP/G
kbind
on (M
21 s
21) (3.760.1)610
8 (2.060.1)610
8 3.8610
8 1.8610
8
kbind
off (s
21) 38614 9 2 627 9 1 2 0
kES1 isom
on (s
21) 30612 8 9 615 9 1 8
kES1 isom
off (s
21) 310613 5 5 621 8 3 2
k
cut (s
21)5 . 5 60.1 N/D 68 97
kEP isom
on (s
21) 2.760.1 N/D N/D N/D
kEP isom
off (s
21) 1.560.1 N/D N/D N/D
aData taken from [29].
doi:10.1371/journal.pone.0024063.t002
Figure 6. Time course of [
32P]-DHU/G substrate cleavage by
APE1K98A (1 mM). The reaction was carried out in NIR buffer.
Concentrations of the substrate are indicated next to the right axis. The
initial region of the kinetic curves is shown on the insert that
corresponds to the phase 1 observed in the time range ,100 s. Phase
2 is observed in the time range 100,t,20000 s. Phase 3 corresponds
to the slow accumulation of cleaved DNA at t.20000 s.
doi:10.1371/journal.pone.0024063.g006
Figure 7. 2-aPu fluorescence traces of the substrate (2-
aPu)DHU/G (1 mM) upon interaction with APE1K98A. The
reaction was carried out in NIR buffer. Smooth black curves are the
result of the fitting procedure. Concentrations of the enzyme are
indicated next to the right axis. The insert shows the initial region
(,20 s) of the fluorescence intensity increase, reaching an intermediate
plateau. This region corresponds to phase 1. Phase 2 is a subsequent
increase in the fluorescence intensity up to ,4000 s. The increase in the
fluorescence intensity at .4000 s corresponds to the beginning of
phase 3.
doi:10.1371/journal.pone.0024063.g007
Figure 8. Trp fluorescence traces of APE1K98A (1 mM) upon
interaction with the substrate DHU/G. The reaction was carried out
in NIR buffer. Smooth curves are the result of the fitting procedure.
Concentrations of the substrate are indicated next to the right axis.
doi:10.1371/journal.pone.0024063.g008
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initial enzyme-substrate binding (kbind
on ) is approximately twofold
higher than in the BER (Table 1). At the same time the reverse
rate constants of the first equilibrium (kbind
off ) are almost the same in
two different buffers. For APE1 (Table 1, [29]) the forward rate
constant of initial unspecific complex formation (kbind
on ) in BER
buffer exceeded the same constant in the NIR buffer by more than
an order of magnitude. At the same time, the reverse rate constant
for this step (kbind
off ) was also more than 10-fold higher in BER
buffer, than in NIR. In BER buffer the formation rate of unspecific
complex (ES)1 of APE1 is 5-fold higher and the stability of this
complex (calculated as kbind
on /kbind
off ) is twofold higher than in the
case of APE1K98A. At the same time in NIR buffer the formation
rate and the stability of complex (ES)1 are higher for APE1K98A
than for APE1 9-fold and 1.5-fold, respectively.
Isomerization of the complex of APE1K98A with an unspecific
substrate occurs faster in BER buffer than in NIR. In BER buffer
the complex (ES)2 is 17-fold more stable than in NIR (the stability
is calculated as kES1 isom
on /kES1 isom
off ). In the case of the wild-type
protein (Table 1, [29]) the rate of isomerization was also greater in
BER buffer than in NIR buffer, and in both buffers it was found
the isomerization occurred faster than in the case of APE1K98A.
The stability of (ES)2 of APE1 exceeds the stability of the
APE1K98A complex in both BER (1.4-fold) and NIR (67-fold)
buffers.
Hence, the substitution of lysine-98 in APE1 by alanine causes
the formation rate and stability of the initial unspecific enzyme-
substrate complex (ES)1 to increase in NIR buffer and decrease in
BER buffer. At the same time, the isomerization rate of the initial
complex and the stability of the complex (ES)2 decrease in both
buffers used. What is more, the stability of complex (ES)2 in NIR
buffer decreases significantly (67-fold).
The data obtained in this work indicate that the mutation K98A
influences the formation of the primary unspecific enzyme-
substrate complex in a complicated manner, depending on the
Mg
2+ concentration and pH. This mutation almost eliminates the
significant differences observed for APE1 between corresponding
constants kbind
on and kbind
off in two buffers used. What is more, the
substitution of Lys-98 by Ala obstructs the induced fit of the
enzyme in the complex with undamaged DNA.
APE1K98A interaction with specific F- and AP-substrates
in BER buffer
In the case of APE1K98A interactions with specific F- and AP-
substrates two reversible steps (initial enzyme-substrate complex
formation and its isomerization) are followed by an irreversible
chemical step of substrate 59-phosphodiester bond hydrolysis, a
reversible step of enzyme-product complex isomerization, and a
reversible step of enzyme dissociation from the complex with
nicked product (Figure 5). As well as in the case of the undamaged
Figure 9. The kinetic scheme describing the interactions of APE1K98A with specific DHU-substrate during NIR.
doi:10.1371/journal.pone.0024063.g009
Table 3. Rate constants of APE1K98A and APE1 interactions with DHU-containing substrates in NIR buffer.
APE1K98A APE1
(a)
Constants DHU/G (from Fig. 8)
[
32P]-DHU/G
(from Fig. 6)
(b)
(2-aPu)DHU/G
(from Fig. 7)
(b) [
32P]-DHU/G (2-aPu)DHU/G
DHU
(2-aPu)/G
kbind
on (M
21 s
21) (9.260.1)610
6
kbind
off (s
21) 8161
kES1 isom
on (s
21) 4.160.1
kES1 isom
off (s
21) 1360.4
kES2 isom
on (s
21) 1.760.1
kES2 isom
off (s
21) 2.260.1
kbind
inact (s
21) (1.960.6)610
24 1.6610
22
k
cut (s
21) 0.2060.01 0.2260.03 0.3060.01 49 53
k
EP isom (s
21) (4.460.7)610
24 3.7610
23 2.7610
23
k
EP diss (s
21)
(c) (1.260.5)610
25 1.3610
25 1.5610
25
aData taken from [24].
bThe amount of enzyme involved in the substrate cleavage was 15% of the initial APE1K98A concentration.
cThe error in k
EP diss includes the contribution of APE1 inactivation as a result of long-term incubation.
doi:10.1371/journal.pone.0024063.t003
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not permit the discovery of the quantity of conformations
possessed by protein at the initial moment. It is conjecture, that
if the protein exists in two conformational forms, the conforma-
tional transition is strongly shifted to the form which is highly
active for AP- and F-substrates cleavage.
For both the wild-type protein and the truncated APE1DN61
lacking the N-terminal 61 amino acids we didn’t register the
isomerization of enzymes in the complex with the nicked product
[29]. Such an isomerization stage probably exists for all three
enzyme forms studied, however only the lysine-98 substitution by
alanine permits the recording of this process. Our hypothesis
explains why the Trp fluorescence intensities do not return to their
initial values on Trp fluorescence traces of interactions of all three
enzyme forms with F- and AP-substrates. Besides, this hypothesis is
in agreement with the data obtained in the study [35].
The lysine-98 substitution by alanine does not have an influence
on the values of forward rate constants of primary complexes
formation (kbind
on ) for F- or AP-substrates, as the corresponding
constants for APE1 and APE1K98A barely differ (Table 2). At the
same time, the reverse rate constant value of formation of primary
complex (kbind
off ) of APE1K98A with substrate F/G decreases
twofold in comparison with APE1 (Table 2). Thus the stability of
the complex (ES)1 of APE1K98A with F/G exceeds the stability of
the corresponding APE1 complex twofold. The forward rate
constant of isomerization of the primary complex with F/G
(kES1 isom
on ) is twofold lower and the reverse constant (kES1 isom
off )i s
17-fold higher for APE1K98A than for APE1 (Table 2). Thereby
in the case of interaction with F-substrate the mutation K98A
leads to a 34-fold decrease in the stability of the catalytically active
complex (ES)2. Moreover, this amino acid substitution leads to a
12-fold decrease in the rate constant value of hydrolysis of 59-
phosphodiester bond (k
cut) in F-substrate (Table 2). In the case of
the natural AP site the mutation K98A leads to a significant
increase in the values of reverse rate constant of formation of
primary enzyme-substrate complex (kbind
off ), and of forward
(kES1 isom
on ) and reverse (kES1 isom
off ) rate constants for isomerization
of this complex (Table 2). Hence, the stability of (ES)1 complex of
mutant protein decreases 4-fold, whereas the stability of (ES)2
complex slightly increases (1.4-fold). The values of the equilibrium
dissociation constants of enzyme-product complexes are almost
identical for APE1K98A (0.44 mM) and APE1 (0.48 mM [29]),
indicating, that lysine-98 does not participate in the equilibrium
dissociation of enzyme from the complex with the nicked product.
Our data reveal that the mutation K98A considerably obstructs
the induced fit leading to the formation of the catalytically active
complex (ES)2 upon interaction of the enzyme with F-containing
DNA. Besides, this mutation decreases the rate of hydrolysis of 59-
phosphodiester bond in F-substrate. The Lys-98 substitution by
Ala appreciably decreases the stability of the primary complex
(ES)1 upon interaction of the enzyme with DNA, containing the
natural AP site. Moreover, this mutation accelerates the
conformational transitions in the enzyme complex with AP-
substrate. APE1 is seen to interact differentially with AP site and
tetrahydrofuran that is widely used as a stable analog of AP site.
Interaction of APE1K98A with specific DHU-substrate in
NIR buffer
We are of the belief (Figure 9) that at the initial moment one
part of APE1K98A exists in the more active conformation E1 in
relation to DHU-substrate binding. The less active form of the
enzyme E2 can either form the initial enzyme–substrate complex
(ES)1 or can be in slow equilibrium with the more active form E1.
The enzyme in the more active form E1, rapidly generates the
initial enzyme-substrate complex (ES)1 that undergoes two
conformational transitions into (ES)2 and (ES)3. These stages are
followed by the hydrolysis of 59-phosphodiester bond of the
substrate with the formation of enzyme complex with the reaction
product (EP)1. (EP)1 then transforms slowly in (EP)2. After that the
limiting process of enzyme E release from the stable complex (EP)2
occurs. In comparison with the kinetic scheme of the DHU-
substrate incision by APE1 [24], in the case of APE1K98A the
scheme contains an additional stage of enzyme-substrate complex
isomerization.
The rate constant kbind
on (Table 3) and the apparent forward rate
constant of formation of primary complex of wtAPE1 with DHU-
substrate (2.9610
6 M
21 s
21 [29]) are of the same order of
magnitude. These constants cannot be compared more precisely.
Hence, in all likelihood, the lysine-98 substitution by alanine does
not have an influence on the value of the forward rate constant of
primary complex formation of E1 with DHU-substrate, us in the
case of F- and AP-substrates. At the same time, in the case of
APE1K98A the value of kbind
inact decreases 84-fold in comparison with
APE1 (Table 3). The rate constant of chemical cleavage of DHU-
substrate is approximately 200-fold lower for the mutant enzyme in
comparison with wild-type protein (Table 3). What is more, the
K98A mutation leads to an order of magnitude decrease in the rate
of slow conformational conversion of enzyme-product complex.
The values of rate constants of the limiting stage of enzymes release
from the complexes with the nicked product (Table 3), as well as the
values of equilibrium dissociation constants of enzyme-product
complexes (KP
APE1K98A=1.9 mM, KP
APE1=1.4 mM [24]) are al-
most the same for both enzyme forms. Thus, Lys-98 substitution
does not influence the stage of dissociation of the enzyme-product
complex.
The rate constant k
cut of DHU-substrate hydrolytic cleavage by
APE1K98A in NIR buffer is approximately 23-fold lower than
corresponding k
cut for F-substrate in BER buffer (Table 2, 3).
While in the case of wtAPE1 k
cut for DHU-substrate in NIR buffer
are only slightly lower than k
cut for F-substrate and nearly twofold
lower than the corresponding constant for AP-substrate in BER
buffer (Table 2, 3). Hence, the substitution of lysine-98 by alanine
influences the catalysis during nucleotide incision repair more than
during base excision repair. In the work [25] the mutant
APE1K98A also was shown to exhibit a more pronounced
reduction of NIR activity compared to BER activity.
The results displayed herein clearly reveal that the substitution
of lysine-98 by alanine significantly delays the activation (see
Figure 9) of the less active form of the enzyme E2, as well as the
hydrolysis of 59-phosphodiester bond of DHU-substrate in the
nucleotide incision repair pathway. Moreover, this amino acid
substitution slows down the conformational conversion of the
complex of enzyme with the product of DHU-substrate cleavage.
In conclusion, we propose that the enzymatic stages shown to be
affected by K98A substitution require the proper coordination of
Mg
2+ in the metal binding site A postulated in [20]. Earlier [10] it
was shown that for the efficient DHU-substrate incision by APE1,
a low magnesium concentration (,2 mM) was required. On the
contrary, the concentration of at least 5 mM MgCl2 was shown to
be necessary for the efficient F-substrate incision [10]. We propose
that the structure of APE1 is more labile at low magnesium
concentration; therefore the protein can reach easier the
conformation allowing the efficient specific interaction with such
bulky lesion as DHU. High magnesium concentration stabilizes
the APE1 conformation optimal for AP-substrate incision. The
K98A substitution leads to the disorder of a hydrogen bonding
network in the metal binding site A. The results presented here
demonstrate that the substitution of lysine-98 by alanine delays the
Kinetics of APE1K98A in BER and NIR Pathways
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more than during base excision repair (5 mM MgCl2). Taken in
tandem, these data suggest that the coordination of Mg
2+ in the
disordered metal binding site A is more efficient at a high
magnesium concentration than at a low concentration. The
divalent metal ion coordinated in the site A is necessary for the
DHU-substrate incision as well as for the incision of AP-site, as we
demonstrate that the K98A mutation influences both the DHU-
and F-substrate cleavage. From these data, we propose that APE1
most probably uses the same active site to catalyze the cleavage of
DHU- and AP-substrates. This correlates with data described in
[36], demonstrating that APE1 appears to use the same active site
to catalyze the cleavage of 3, N
4-benzetheno-dC and AP-site.
Although in the study [19] the APE1 hydrophobic pocket
interacting with the hydrophobic side of the abasic deoxyribose
was shown to be specific for the a-anomer of the natural AP site,
the protein is probably able to form the conformation, providing
the proper orientation of DHU in the active site.
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